Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability - Bandinelli, Francesca; Scazzariello, Francesco; Pimenta da Fonseca, Emanuela; Mittermayer Barreto, Santiago; Marcassa, Claudio; Nacci, Francesca; Matucci Cerinic, Marco (Drug design, development and therapy, 2016)
Keywords: Adult; Aged; Aged, 80 and over; Ankylosing spondylitis; Anti-Inflammatory Agents - administration & dosage; Anti-Inflammatory Agents - adverse effects; Arthritis; Cohort Studies; Controlled release technology; Cytokines; Dosage and administration; Drug dosages; Drug therapy; Female; Glucocorticoids; Humans; Immune system; Inflammation; Inflammatory bowel disease; Inflammatory diseases; Male; Middle Aged; modified-release prednisone; morning stiffness; Nonsteroidal anti-inflammatory drugs; Original Research; Pain; Pain - drug therapy; Prednisolone; Prednisone; Prednisone - administration & dosage; Prednisone - adverse effects; Retrospective Studies; Rheumatic diseases; Rheumatoid arthritis; Rheumatology; Safety; Short term; Side effects; Signs and symptoms; Spondylarthritis - drug therapy; Spondylarthritis - physiopathology; Spondylitis; Spondylitis, Ankylosing - drug therapy; Spondylitis, Ankylosing - physiopathology; spondyloarthritis; Spondyloarthropathies; Stiffness; Substance abuse treatment; Testing; Tumor necrosis factor-TNF; Italy; modified-release prednisone; spondyloarthritis; glucocorticoids; morning stiffness